HCA Healthcare, Inc. (HCA) Presents at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Transcript

Business Performance - The company reported a solid performance in 2025, handling 47 million patient encounters across 43 markets [1] - There was a year-over-year adjusted admission growth across all domestic divisions, resulting in a total admission growth of 2.4% for the year [1] - The company effectively managed expenses, leading to a 90 basis point improvement in EBITDA margin, which reached 20.6% for the year [1] Strategic Focus - In 2026, the company plans to maintain its focus on its strategic agenda while being prudent with capital deployment [2] - Continued investments will be made in digital and AI initiatives, indicating a commitment to innovation and technology [2]